We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$325B
AUM Growth
+$19.8B
Cap. Flow
+$3.2B
Cap. Flow %
0.99%
Top 10 Hldgs %
12.37%
Holding
6,814
New
216
Increased
2,666
Reduced
3,277
Closed
152

Sector Composition

Rank Sector Weight
1 Financials 9.69%
2 Technology 9.44%
3 Healthcare 8.03%
4 Consumer Discretionary 7.35%
5 Communication Services 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMN icon
6176
ProShares UltraShort Materials
SMN
$3.97M
$4K ﹤0.01%
15
-8
-35% -$2.44K
TLF icon
6177
Tandy Leather Factory
TLF
$19.8M
$4K ﹤0.01%
500
+200
+67% +$1.57K
XENE icon
6178
Xenon Pharmaceuticals
XENE
$6.13B
$4K ﹤0.01%
1,055
-81
-7% -$637
XTNT icon
6179
Xtant Medical Holdings
XTNT
$57.7M
$4K ﹤0.01%
542
-83
-13% -$510
TRAW icon
6180
Traws Pharma
TRAW
$6.92M
0
OPGN
6181
DELISTED
OpGen, Inc
OPGN
0
RJZ
6182
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Metals Total Return
RJZ
$4K ﹤0.01%
+500
New +$4.03K
SRRA
6183
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4K ﹤0.01%
61
-402
-87% -$23.4K
TRIL
6184
DELISTED
Trillium Therapeutics Inc.
TRIL
$4K ﹤0.01%
+700
New +$4.1K
IOTS
6185
DELISTED
Adesto Technologies Corp
IOTS
$4K ﹤0.01%
1,000
COF.WS
6186
DELISTED
Capital One Financial Corp
COF.WS
$4K ﹤0.01%
100
YGE
6187
DELISTED
Yingli Green Energy Holding Comp
YGE
$4K ﹤0.01%
2,230
+1,626
+269% +$4.15K
ONSIZ
6188
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$4K ﹤0.01%
8,950
CRTN
6189
DELISTED
Cartesian, Inc.
CRTN
$4K ﹤0.01%
5,421
BONT
6190
DELISTED
Bon-Ton Stores Inc/The
BONT
$4K ﹤0.01%
4,510
-15,375
-77% -$17.4K
WSTL
6191
DELISTED
Westell Technologies Inc
WSTL
$4K ﹤0.01%
1,441
-286
-17% -$782
CHII
6192
DELISTED
Global X MSCI China Industrials ETF
CHII
$4K ﹤0.01%
269
SZO
6193
DELISTED
DB Crude Oil Short Exchange Traded Notes due June 1, 2038
SZO
$4K ﹤0.01%
50
KONE
6194
DELISTED
Kingtone Wirelessinfo Solution Holding Ltd
KONE
$4K ﹤0.01%
1,200
+425
+55% +$1.61K
PTM
6195
DELISTED
E-TRACS UBS Long Platinum ETN
PTM
$4K ﹤0.01%
352
AKTX
6196
Akari Therapeutics
AKTX
$14M
0
ARKR icon
6197
Ark Restaurants
ARKR
$20.4M
$3K ﹤0.01%
104
-136
-57% -$3.34K
CAAS icon
6198
China Automotive Systems
CAAS
$134M
$3K ﹤0.01%
600
-4,500
-88% -$22.6K
KUST
6199
Kustom Entertainment Inc
KUST
$853K
0
GRF
6200
Eagle Capital Growth Fund
GRF
$40M
$3K ﹤0.01%
462

Similar funds

Morgan Stanley's Q1 2017 Portfolio in Review

As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.

  • Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
  • Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
  • Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
  • Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
  • Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
  • Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.